Smooth Muscle And Endothelial Function Of Arterial Grafts For Coronary Artery Bypass Surgery
- 3 July 2002
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 29 (8) , 717-720
Abstract
SUMMARY: 1. Various small/mid‐sized conductance arteries have been used for coronary artery bypass grafting as arterial grafts, but unanimous opinion to the best use of these grafts has not been formed.2. Arterial grafts are not uniform in their biological characteristics.3. The differences among the arteries may involve the contractility of the vessel. Based on studies of the contractility of arterial grafts, a clinical classification was formed to describe the tendency of vasospasm in the arterial grafts.4. The differences among arterial grafts also involve endothelial function. This refers to both nitric oxide release from the endothelium, as well as endothelium‐derived hyperpolarizing factor‐mediated hyperpolarization and relaxation.5. The difference in the peri‐operative behaviour of the grafts and in their long‐term patency may be related to different characteristics. These should be taken into account in the use of arterial grafts, some of which are subject to more active pharmacological intervention during and after operation to obtain satisfactory results. The clinical choice of grafts must be based on the general condition of the patient, the biological characteristics of the graft, the anatomy of the coronary artery, the match between the coronary artery and the graft and the technical considerations, including antispastic management.Keywords
This publication has 27 references indexed in Scilit:
- Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: Comparison with papaverine solutionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass graftsBritish Journal of Clinical Pharmacology, 1997
- Comparison of nitroprusside and nitroglycerin in inhibition of angiotensin II and other vasoconstrictor‐mediated contraction in human coronary bypass conduitsBritish Journal of Clinical Pharmacology, 1997
- Inhibition of Vasoconstriction by Phosphodiesterase III Inhibitor Milrinone in Human Conduit Arteries Used as Coronary Bypass GraftsJournal of Cardiovascular Pharmacology, 1996
- 5-HT1-Like Receptor-Mediated Contraction in the Human Internal Mammary ArteryJournal of Cardiovascular Pharmacology, 1996
- Effect of Thromboxane A2 Antagonist GR32191B on Prostanoid and Nonprostanoid Receptors in the Human Internal Mammary ArteryJournal of Cardiovascular Pharmacology, 1995
- Fifteen- to twenty-one-year angiographic assessment of internal thoracic artery as a bypass conduitThe Annals of Thoracic Surgery, 1994
- Action of vasoactive intestinal peptide and distribution of its binding sites in vessels used for coronary artery bypass graftsThe American Journal of Cardiology, 1993
- Difference between Endothelium-Dependent Relaxation in Arterial and in Venous Coronary Bypass GraftsNew England Journal of Medicine, 1988
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986